Allegion - ALLE Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Allegion in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ALLE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALLE, but not buy additional shares or sell existing shares.
View ALLE analyst ratings or view top-rated stocks.

9 equities research analysts have issued twelve-month price targets for Allegion's shares. Their ALLE share price forecasts range from $107.00 to $127.00. On average, they predict the company's share price to reach $114.88 in the next year. This suggests a possible upside of 0.7% from the stock's current price.
View analysts price targets for ALLE or view top-rated stocks among Wall Street analysts.

Allegion's stock was trading at $132.44 at the beginning of 2022. Since then, ALLE stock has decreased by 13.9% and is now trading at $114.06.
View the best growth stocks for 2022 here.

Allegion saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 1,790,000 shares, a decrease of 11.4% from the October 31st total of 2,020,000 shares. Based on an average daily volume of 794,500 shares, the days-to-cover ratio is currently 2.3 days. Approximately 2.1% of the company's stock are short sold.
View Allegion's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our ALLE earnings forecast.

Allegion plc (NYSE:ALLE) issued its earnings results on Thursday, October, 27th. The scientific and technical instruments company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.45 by $0.19. The scientific and technical instruments company had revenue of $913.70 million for the quarter, compared to analysts' expectations of $873.58 million. Allegion had a net margin of 13.96% and a trailing twelve-month return on equity of 59.82%. The company's revenue was up 27.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.56 earnings per share.
Read the conference call transcript.

Allegion declared a quarterly dividend on Thursday, December 1st. Shareholders of record on Friday, December 16th will be given a dividend of $0.41 per share on Friday, December 30th. This represents a $1.64 annualized dividend and a yield of 1.44%.
Read our dividend analysis for ALLE.

Allegion (NYSE:ALLE) pays an annual dividend of $1.64 per share and currently has a dividend yield of 1.44%. The company has been increasing its dividend for 8 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 33.40%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ALLE will have a dividend payout ratio of 26.80% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ALLE.

Allegion issued an update on its FY 2022 earnings guidance on Thursday, November, 3rd. The company provided earnings per share (EPS) guidance of $5.40-$5.50 for the period, compared to the consensus estimate of $5.37. The company issued revenue guidance of $3.24 billion-$3.27 billion, compared to the consensus revenue estimate of $3.23 billion.

141 employees have rated Allegion Chief Executive Officer David (Dave) D. Petratis on Glassdoor.com. David (Dave) D. Petratis has an approval rating of 90% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Allegion investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Johnson & Johnson (JNJ), Walmart (WMT), Citigroup (C), AT&T (T), UnitedHealth Group (UNH), Cisco Systems (CSCO) and Nucor (NUE).

Allegion trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALLE."

Allegion's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.94%), BlackRock Inc. (8.48%), State Street Corp (4.46%), Boston Partners (4.33%), Kayne Anderson Rudnick Investment Management LLC (3.36%) and AKO Capital LLP (3.06%). Insiders that own company stock include David D Petratis, David D Petratis, Douglas P Ranck, Jeffrey N Braun, John H Stone, Patrick S Shannon, Robert C Martens, Shelley A Meador, Timothy P Eckersley, Timothy P Eckersley and Tracy L Kemp.
View institutional ownership trends.

Shares of ALLE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALLE stock can currently be purchased for approximately $114.06.

Allegion (NYSE:ALLE) has a market capitalization of $10.02 billion and generates $2.87 billion in revenue each year. The scientific and technical instruments company earns $483 million in net income (profit) each year or $4.91 on an earnings per share basis.

The company employs 11,000 workers across the globe.

Allegion's mailing address is BLOCK D IVEAGH COURT HARCOURT ROAD, DUBLIN L2, 46032. The official website for the company is www.allegion.com. The scientific and technical instruments company can be reached via phone at (531) 254-6200 or via email at michael.wagnes@allegion.com.